drugset / Trial / NCT04536961
A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the drug levels of BMS-986165 in when taken by mouth as various solid tablet prototypes, by healthy participants.
Timeline
- Start
- 2020-09-10
- Primary completion
- 2020-12-25
- Completion
- 2020-12-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CRAVACITINIB | Small molecule | — | Oral |
| Background | Famotidine | Other / unclassified | — | — |
Indications
No indication recorded.